Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
SPRY | US
-0.26
-1.80%
Healthcare
Biotechnology
30/06/2024
04/10/2024
14.19
14.18
14.39
13.85
ARS Pharmaceuticals Inc. a biopharmaceutical company develops treatments for patients and parents affected by severe allergic reactions. It is developing neffy a needle-free and low-dose intranasal epinephrine nasal spray for patients and their caregivers with type I allergic reactions including anaphylaxis. The company was founded in 2015 and is based in San Diego California.
View LessLow Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Strong Revenue Growth (> 10%)
Strong Sharpe Ratio (> 1.2)
Price Below SMA10D
Smallcap (300M - 2B USD)
High Short percentage (> 15%)
Weak Operating Margin (< 10%)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
38.4%1 month
53.5%3 months
76.6%6 months
64.5%-
-
6.45
0.00
0.00
-9.88
2.34K
-
-56.67M
1.38B
1.38B
-
-3.07K
-
4.90K
-19.34
8.00
22.62
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
1.92
Range1M
4.22
Range3M
7.64
Rel. volume
0.68
Price X volume
9.75M
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Rocket Pharmaceuticals Inc | RCKT | Biotechnology | 16.41 | 1.49B | -3.24% | n/a | 6.71% |
IRON | IRON | Biotechnology | 49.93 | 1.48B | -2.48% | n/a | 0.38% |
Cassava Sciences Inc | SAVA | Biotechnology | 27.08 | 1.45B | 0.52% | n/a | 0.00% |
Dynavax Technologies Corporation | DVAX | Biotechnology | 11.02 | 1.44B | -2.91% | 84.62 | 39.71% |
NRIX | NRIX | Biotechnology | 22.2 | 1.43B | 1.05% | n/a | 7.77% |
Longboard Pharmaceuticals Inc. Common Stock | LBPH | Biotechnology | 36.22 | 1.41B | -0.55% | n/a | 1.31% |
Xencor Inc | XNCR | Biotechnology | 19.85 | 1.39B | 2.00% | n/a | 15.54% |
Day One Biopharmaceuticals Inc. Common Stock | DAWN | Biotechnology | 14.1 | 1.39B | 3.52% | n/a | 0.06% |
Kura Oncology Inc | KURA | Biotechnology | 18.04 | 1.38B | -2.49% | n/a | 3.59% |
Tarsus Pharmaceuticals Inc | TARS | Biotechnology | 33.89 | 1.31B | 3.48% | n/a | 28.62% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Steelcase Inc | SCS | Building Products & Equipment | 12.97 | 1.47B | 0.78% | 12.50 | 65.47% |
REV Group Inc | REVG | Recreational Vehicles | 27.56 | 1.43B | 0.00% | 6.15 | 63.13% |
Janus International Group Inc. | JBI | Building Products & Equipment | 9.79 | 1.42B | 2.73% | 11.54 | 116.21% |
Pitney Bowes Inc | PBI | Building Products & Equipment | 6.92 | 1.24B | 1.91% | n/a | -571.93% |
ARLO TECHNOLOGIES INC | ARLO | Building Products & Equipment | 11.47 | 1.15B | 0.09% | n/a | 19.46% |
Camping World Holdings Inc | CWH | Recreational Vehicles | 23.44 | 1.06B | -0.38% | n/a | 3644.76% |
Malibu Boats Inc | MBUU | Recreational Vehicles | 39.7 | 793.63M | -0.68% | n/a | 1.50% |
Latham Group Inc. | SWIM | Building Products & Equipment | 6.64 | 767.43M | 0.00% | 61.27 | 77.00% |
Ennis Inc | EBF | Building Products & Equipment | 24.31 | 631.67M | 2.36% | 15.15 | 2.42% |
ACCO Brands Corporation | ACCO | Building Products & Equipment | 5.25 | 502.94M | -0.19% | n/a | 174.23% |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | -9.88 | 0.76 | Cheaper |
Ent. to Revenue | 2,339.24 | 3,674.48 | Cheaper |
PE Ratio | - | 38.01 | - |
Price to Book | 6.45 | 14.10 | Cheaper |
Dividend Yield | - | 2.22 | - |
Std. Deviation (3M) | 76.64 | 74.67 | Par |
Debt to Equity | 0.00 | -1.82 | Expensive |
Debt to Assets | 0.00 | 0.26 | Cheaper |
Market Cap | 1.38B | 3.73B | Emerging |